- Review
Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor
- Mackayla L. Nelson,
- Julia A. Pfeifer,
- Jordan P. Hickey,
- Andrila E. Collins and
- Bettina E. Kalisch
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that debilitates over 55 million individuals worldwide. Currently, treatments manage and alleviate its symptoms; however, there is still a need to find a therapy that prevents...

